Topic
Benzopyran
About: Benzopyran is a research topic. Over the lifetime, 1889 publications have been published within this topic receiving 15235 citations.
Papers published on a yearly basis
Papers
More filters
•
01 Nov 2017
••
TL;DR: In this article, 3-(aryloxyacetyl)-2,3-dihydrothieno[3,2-c ][1] benzopyran-4-ones 5a-f were synthesised in 70-75% yields by the application of the sulfoxide rearrangement of 4-(4-aryloxybut-2-ynylthio)[1]benzopyrans 2-ones 4a -f.
Abstract: Hitherto unreported 3-(aryloxyacetyl)-2,3-dihydrothieno[3,2- c ][1] benzopyran-4-ones 5a – f were synthesised in 70–75% yields by the application of the sulfoxide rearrangement of 4-(4-aryloxybut-2-ynylthio)[1]benzopyran-2-ones 4a – f . The substrates 4a – f were synthesised by phase-transfer-catalysed alkylation of previously unreported 4-mercaptocoumarin.
•
31 Mar 2006
TL;DR: In this paper, N-hydroxy-2-dodecyl-6-hydroxyl-2,5,7,8-tetramethyl-2H-1-benzopyran-2carboxamide derivatives of formula (II) are new.
Abstract: N-hydroxyalkyl-6-hydroxy-2-alkyl-2H-1-benzopyran-2-carboxamide derivatives (II) are new. N-hydroxyalkyl-6-hydroxy-2-alkyl-2H-1-benzopyran-2-carboxamide derivatives of formula (II) are new. R51-4C alkyl; R6-R8H, OH or 1-4C alkyl; and R : 2-30C alkyl. An independent claim is also included for preparing (I). [Image] ACTIVITY : Nootropic; Dermatological; Neuroprotective; Cytostatic; Cardiovascular-Gen. MECHANISM OF ACTION : Radical scavenger. N-(1-hydroxy-2-dodecyl)-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-carboxamide reduced UV absorption (517 nm) of a 100 mu M diphenylpicrylhydrazide radical solution by 65% at a concentration of 20 mu M, compared with 71% for methyl gallate and 70% for N-(1-hydroxy-2-dodecyl)-3,4,5-trihydroxybenzamide and 91% for 6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-carboxylic acid.
•
19 Mar 2015TL;DR: In this paper, a method for preparing a benzopyran compound and uses in protecting against pulmonary fibrosis is presented, which is obtained from a fermentation liquid of Streptomyces xiamenensis (CGMCC No.5675).
Abstract: Disclosed are a method for preparing a benzopyran compound and uses in protecting against pulmonary fibrosis. The structural formula of the benzopyran compound is shown by formula (I), R1 being one selected from hydrogen, C1-C4 alkyl and residual groups of various amino acids after removing amino parts, R2 being one selected from hydrogen, C1-C4 alkyl and residual groups of various amino acids after removing amino parts, R3 being one selected from hydrogen, C1-C4 alkyl and residual groups of various amino acids after removing amino parts, and n being any integer of 1 to 4. The benzopyran compound is obtained from a fermentation liquid of Streptomyces xiamenensis (CGMCC No.5675) by extraction, separation and purification. The Streptomyces xiamenensis extract derivative prepared in the present invention has higher performance of inhibiting the proliferation and activity of health human lung fibroblasts, and can be used for preparing anti-pulmonary fibrosis drugs.
••
TL;DR: In this paper, cyclopenta-fused benzopyran and naphthalene derivatives are prepared using a spirobiindane-based chiral phosphine as catalyst.
Abstract: Cyclopenta-fused benzopyran and naphthalene derivatives are prepared using a spirobiindane-based chiral phosphine as catalyst.